MedTrace Logo

Interventions to Increase Screening by Breast Cancer Survivors and Their High Risk Female Relatives

NCT01612338 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1290

Last updated 2019-08-22

No results posted yet for this study

Summary

The University of Michigan (UM) Schools of Nursing, Public Health, and Medicine, the Michigan Department of Community Health (MDCH) and the Michigan Cancer Consortium (MCC) are conducting a multidisciplinary academic/practice three-year project to increase appropriate breast cancer screening for young breast cancer survivors and their cancer-free, female relatives at greatest risk for breast cancer. The aims of this project are to: 1) identify and survey 3000 breast cancer survivors reported to the Michigan Cancer Surveillance Program who were diagnosed between the ages of 20-45 years regarding their breast cancer screening utilization; 2) identify and survey the survivors' female relatives regarding their breast cancer screening utilization; and 3) implement two versions (targeted vs. enhanced tailored) of an evidence-based intervention recommended by the Guide to Community Preventive Services to increase breast cancer screening. A follow-up survey will assess the effectiveness of each intervention on a) breast cancer screening utilization; b) perceived barriers and facilitators to screening; c) self-efficacy in utilizing screening services; d) family support related to screening; e) knowledge of the genetics of breast cancer and personal risk factors; and f) satisfaction with the intervention.

Conditions

  • Breast Cancer
  • Breast Cancer in Young Women
  • Breast Cancer in Women With a Strong Family History

Interventions

BEHAVIORAL

Targeted

Targeted letter and booklet

BEHAVIORAL

Enhanced Tailored

Tailored letter and booklet, enhanced family communication and support brochure

Sponsors & Collaborators

Principal Investigators

  • Maria C. Katapodi, PhD · University of Michigan School of Nursing

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-07-31
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01612338 on ClinicalTrials.gov